IBM (Armonk, N.Y.) and Nuance Communications Inc. (Burlington, Mass.) announced a research agreement to explore, develop, and commercialize the Watson computing system's advanced analytics capabilities in the healthcare industry.
The research and technology initiative will combine IBM’s Deep Question Answering (QA), Natural Language Processing, and Machine Learning capabilities with Nuance's speech recognition and Clinical Language Understanding (CLU) solutions for the diagnosis and treatment of patients that provide hospitals, physicians and payers access to critical and timely information. The two companies expect the first commercial offerings from the collaboration to be available in 18-24 months.
Additionally, Columbia University Medical Center and the University of Maryland School of Medicine are contributing their medical expertise and research to the collaborative effort. For example, physicians at Columbia University are helping identify critical issues in the practice of medicine where the Watson technology may be able to contribute, and physicians at the University of Maryland are working to identify the best way that a technology
Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.